The drug maker Takeda Chemical Industries said sales in the October to December period grew 3.7 percent in comparison with the same quarter a year earlier, citing sales of the company's drugs for diabetes and hypertension. Takeda said sales hit 297 billion yen ($2.8 billion) in the quarter. The company, which is based in Osaka, kept its profit forecast for the full year ending on March 31 unchanged at 266 billion yen ($2.5 billion).
Ken Belson (NYT)
